Drug Type Therapeutic vaccine, Conjugated vaccine |
Synonyms MenACYWX, Meningococcal vaccine groups A, C, W-135, Y, X conjugate, Meningococcal-ACYWX-conjugate-vaccine + [4] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Meningitis | Phase 3 | ML | 24 Mar 2022 | |
Meningococcal Infections | Phase 3 | IN | 27 Dec 2019 | |
Meningitis, Meningococcal | Phase 2 | ML | 15 Nov 2017 |
Phase 3 | 1,325 | (Vaccination at 9 Months of Age With NmCV-5) | yqtvkyasek(ylnvpmycns): Difference in proportions = 0.0 (95% CI, -1.0 to 2.0); Difference in proportions = -0.5 (95% CI, -2.3 to 1.9); Difference in proportions = -3.0 (95% CI, -6.3 to 0.8); Difference in proportions = -3.0 (95% CI, -5.4 to -0.4) View more | - | 07 May 2024 | ||
MenACWY-TT (Vaccination at 9 Months of Age With MenACWY-TT) |